 |
市場調査レポート
商品コード
1345215
ライフサイエンスおよび分析機器の世界市場 - 市場規模、シェア、成長分析：技術別（NGS、PCR）、用途別（研究用途、臨床・診断用途）- 業界予測（2023年～2030年）Global Life Sciences and Analytical Instruments Market Size, Share, Growth Analysis, By Technology(NGS, PCR), By Application(Research applications and Clinical & diagnostic applications) - Industry Forecast 2023-2030 |
||||||
| ライフサイエンスおよび分析機器の世界市場 - 市場規模、シェア、成長分析：技術別（NGS、PCR）、用途別（研究用途、臨床・診断用途）- 業界予測（2023年～2030年） |
|
出版日: 2023年06月05日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
ライフサイエンスおよび分析機器の市場規模は、2021年に714億米ドルとなりました。同市場は、予測期間（2023年～2030年）に7%のCAGRで拡大し、2022年の765億6,000万米ドルから2030年には1,304億7,000万米ドルに成長する見通しです。
ライフサイエンスおよび分析機器は、研究所、病院、診療所、バイオテクノロジーや製薬会社など、さまざまな分野で応用されています。その有用性は、最終製品と原材料の両方の検査と検証にあります。これらのツールは、商品の品質と安全性を確保する上で極めて重要であり、潜在的な危険から保護しながら、様々な産業で正確な評価を可能にします。
地域別に見ると、世界のライフサイエンスおよび分析機器市場は北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにまたがります。注目すべきは北米で、2022年の市場収益の約38％を占め、圧倒的な存在感を示しています。医薬品研究開発への投資が活発化しており、業界リーダーには展望が開けています。さらに、製品の完全性に関する規制当局の監視が強化され、飲食品分野での採用が加速しています。ドイツが主導する欧州は、医薬品研究と技術的進歩で繁栄しています。アジア太平洋は、インドと中国のダイナミックな拡大に牽引され、製薬業界の進歩に起因する力強い成長を示しています。
バイオテクノロジーや製薬などの業界は、研究開発（R&D）に多大な資源を投入しています。これは、創薬を迅速化し、希少疾患をターゲットとした治療薬の革新的な上市を促進することを目的としています。国際製薬団体連合会（IFPMA）は、製薬セクターの年間研究開発投資額が1,500億米ドルを超えると報告しています。7,000を超える新規化合物が開発され、56の新薬が開発されています。迅速で効果的なライフサイエンスツールは、特に心血管疾患、神経疾患、癌、感染症などの疾患に対する医薬品開発を早める上で極めて重要な役割を果たしており、世界のライフサイエンスおよび分析機器市場を牽引しています。
ライフサイエンスおよび分析機器分野の拡大に対する阻害要因としては、機器費用の高騰、公衆衛生意識の低下、実現可能な代替オプションの存在などが予想されます。コストの上昇は採用を抑制し、十分な認知度は需要を制限し、実行可能な代替手段の存在は従来のライフサイエンスおよび分析機器から投資や関心を遠ざける可能性があるため、業界の成長軌道はこれらの要因によって制約を受ける可能性があります。
当レポートは、世界のライフサイエンスおよび分析機器市場について調査し、市場の概要とともに、技術別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。
目次
エグゼクティブサマリー
親市場分析
市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要な市場の洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 動向分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品分析
- マクロ経済指標
- トップ投資分析
- 主な成功要因
- 競合の程度
市場力学と展望
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制状況
- ポーター分析
世界のライフサイエンスおよび分析機器市場、技術別
- 市場概要
- NGS
- PCR
- 分光法
- 顕微鏡検査
世界のライフサイエンスおよび分析機器市場、用途別
- 市場概要
- 研究用途と臨床および診断用途
世界のライフサイエンスおよび分析機器市場、地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
競合情勢
- 主要企業プロファイル
- Agilent Technologies Inc.
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- PerkinElmer Inc.
- Bruker Corporation
- Waters Corporation
- Shimadzu Corporation
- Merck KGaA
- GE Healthcare
- bioMerieux SA
- Hitachi High-Technologies Corporation
- Bio-Rad Laboratories Inc.
- Olympus Corporation
- Beckman Coulter Inc.
- Eppendorf AG
- Illumina Inc.
- Qiagen N.V.
- Becton, Dickinson and Company
- Hologic Inc.
- Sartorius AG
Life Sciences and Analytical Instruments Market size was valued at USD 71.4 billion in 2021 and is poised to grow from USD 76.56 billion in 2022 to USD 130.47 billion by 2030, growing at a CAGR of 7% in the forecast period (2023-2030).
Life science and analytical instruments find applications across diverse sectors such as laboratories, hospitals, clinics, as well as biotechnology and pharmaceutical companies. Their utility lies in the examination and validation of both end products and raw materials. These tools are pivotal in ensuring the quality and safety of goods, enabling precise evaluations in various industries while safeguarding against potential hazards. Global life sciences and analytical instruments market is segmented on the basis of technology, application and region. On the basis of Technology, global market is segmented into Spectroscopy, PCR, Next-Generation Sequencing (NGS), Microscopy, Flow Cytometry and Chromatography. On the basis of application, global market is segmented into research applications and clinical & diagnostic applications. On the basis of region, global market is divided into North America, Europe, Asia-Pacific, Latin America, and MEA.
Segmented by geography, the global market for life sciences and analytical instruments spans North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Notably, North America emerged as the dominant player, constituting approximately 38% of the market's revenue in 2022. Heightened investments in pharmaceutical R&D offer prospects for industry leaders. Additionally, escalated regulatory scrutiny regarding product integrity fuels adoption within the food and beverage sector. Europe, led by Germany, thrives on pharmaceutical research and technological strides. Asia-Pacific, driven by dynamic expansions in India and China, showcases robust growth attributed to advancing pharmaceutical industries.
Top-down and bottom-up approaches were used to estimate and validate the size of the Life Sciences and Analytical Instruments Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Driver:
Industries like biotechnology and pharmaceuticals are committing substantial resources to research and development (R&D) endeavors. This is aimed at expediting drug discovery and facilitating the innovative launch of therapeutic agents targeting rare ailments. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) reports an annual R&D investment exceeding US$ 150 billion within the pharmaceutical sector. Over 7,000 novel compounds have been formulated, introducing 56 new drugs. Swift and effective life science tools play a pivotal role in hastening drug development, particularly for conditions such as cardiovascular diseases, neurological disorders, cancer, and infectious diseases, thereby propelling the global life sciences and analytical instruments market.
Restraint:
Anticipated impediments to the expansion of the life science and analytical equipment sector encompass escalating instrument expenditures, limited public health awareness, and the presence of feasible alternative options. The industry's growth trajectory might be constrained by these factors, as higher costs could deter adoption, insufficient awareness might limit demand, and the existence of viable alternatives could divert investment and interest away from traditional life science and analytical tools.
Key Market Trends:
Chromatography has gained prominence in analytical chemistry due to its remarkable attributes including precise separation capabilities, reproducibility, and rapid separation processes. A significant market trend involves its widespread application in pharmaceutical contexts, such as quantifying drug compounds. The rising utilization of chromatography assays in drug validation and augmented government funding bolster the market's anticipated expansion. These factors collectively underpin the projected market growth throughout the forecast period.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Life Sciences and Analytical Instruments Market by Technology
- Market Overview
- NGS
- PCR
- Spectroscopy
- Microscopy
- Global Life Sciences and Analytical Instruments Market by Application
- Market Overview
- Research applications and Clinical & diagnostic applications
- Global Life Sciences and Analytical Instruments Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Agilent Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bruker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Waters Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shimadzu Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- bioMerieux SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hitachi High-Technologies Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Olympus Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Beckman Coulter Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eppendorf AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Illumina Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Qiagen N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hologic Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- On August 1, 2022, Thermo Fisher Scientific, Inc., a global leader in scientific services, introduced the Thermo Scientific Arctis Cryo-Plasma Focused Ion Beam (Cryo-PFIB), a new network and automated microscope designed to accelerate cryo-electron tomography (Cryo-ET) research
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
